4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000063
Chief Medical Officer sold 7,947 shares at an average $69.28 ($550,607)
- Chief Medical Officer acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goncalves Joana · Chief Medical Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,500 | $6.84 | $23,940 | 37,165 | D |
| 2026-06-15 | Exercise or conversion : show line 2 in the form 10b5-1 | +3,500 | $7.80 | $27,300 | 40,665 | D |
| 2026-06-15 | Sale : show line 3 in the form 10b5-1 | −1,636 | $68.38 | $111,876 | 39,029 | D |
| 2026-06-15 | Sale : show line 4 in the form 10b5-1 | −5,064 | $69.42 | $351,547 | 33,965 | D |
| 2026-06-15 | Sale : show line 5 in the form 10b5-1 | −300 | $70.62 | $21,187 | 33,665 | D |
| 2026-06-15 | Sale : show line 6 in the form 10b5-1 | −947 | $69.69 | $65,996 | 32,718 | D |
| Open-market sales · 7,947 sh · avg $69.28 · $550,607 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-15 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) | −3,500 | 204,063 | D |
| 2026-06-15 | Exercise or conversion : show line 8 in the form 10b5-1 Employee Warrant (right to buy) | −3,500 | 175,492 | D |
Loading xslF345X06/form4.xml…